title: Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
authors.forename: Myung-Jin
authors.initials: MJ
authors.lastname: Choi
authors.forename: Young Kyoung
authors.initials: YK
authors.lastname: Park
authors.forename: Kyong Ran
authors.initials: KR
authors.lastname: Peck
authors.forename: Kwan Soo
authors.initials: KS
authors.lastname: Ko
mesh_terms: D000151:Acinetobacter Infections / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D000890:Anti-Infective Agents / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology*; D004347:Drug Interactions; D024881:Drug Resistance, Bacterial; D006801:Humans; D007710:Klebsiella Infections / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D009154:Mutation; D011552:Pseudomonas Infections / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification
chemical_list: D000890:Anti-Infective Agents; D003091:Colistin